Nervous System Disorders

Category: Neurology, HIC#13381
Title:
A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day Monotherapy in Subjects with Partial-onset Seizures.
Contact:Bruce Palmer
Phone:(434)924-1142
E-mail:bap7n@virginia.edu

UVa Health System, Neurology Department, F.E. Dreifuss Comprehensive Epilepsy Program seeks Women, Men, ages 16-70 with partial seizures and are taking 1 or 2 anti-epileptic drugs for research study.

The purpose of the study is to see if the investigational drug, when taken alone, affects the type, number, length and severity of seizures. Another purpose of the study is to find out if there are side effects when the investigational drug is used without other anti-epileptic drugs.
Your participation in this study will require 14 study visits over 30 weeks. Each visit will last 1 to 2 hours.


Study-related exams, and tests provided free of charge.

You will be compensated $50.00 for time and travel for all completed study related office visits.

Contact Information:
For more information please contact:
" Stacy Thompson, RN, BSN, CCRC, Src2h@virginia.edu
" 434-982-4315
" HIC# 13381

Principal Investigator: Nathan Fountain MD

Primary Investigator: Fountain Nathan, B
Department: Neurology
Division: General Neurology
Accepts adult enrollment :YES
Accepts minor enrollment :YES